Time-to-clinic and the development of novel medicines and goods are being slowed because the supply of suitable cleanrooms has not kept pace with the industry's rapid expansion. Cleanrooms provide a conundrum for the pharmaceutical industry, which must decide whether to construct its own facility, investing years and millions of dollars in validation, or to outsource the work to a contract manufacturing company.
read more..